Global Cannabinoid Drugs Market: Overview
Cannabinoids are organic chemical compounds found not just in the oft recognized plant Cannabis sativa, but also in the human neural networks. In the brain and spinal cord they act as pain relieving molecules that serve to diminish incoming pain signals and provide relief from long term discomfort. This particular property makes them lucrative for pain management.
Request Brochure –
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=78851
Besides their recreational usage, cannabinoids find widespread use in the healthcare industry. Here, they act as pain relievers and mood stabilizers, and being organic the acceptance of this therapy is good among patients. Accordingly, few conditions they are used for are chronic pain of any origin, side effects such as vomiting and nausea associated with chemotherapy, anorexia, weight loss, IBS, spasticity, epilepsy, and a variety of psychiatric conditions. This is helping the global cannabinoid drug market record sturdy growth over the assessment period of TMR’s upcoming report – 2024 to 2030.
Global Cannabinoid Drugs Market: Competitive Landscape
The number of players in the cannabinoid drug market is few, making the market scenario concentrated. These manufactures are engaged in improving infrastructure and funding innovation to help increase operational footprint. This is anticipated to help increase production to cater to increasing demands for cannabinoid drugs globally. Some of the prominent names in this market are:
- GW Pharmaceuticals
- Abbott Laboratories,
- Valeant Pharmaceuticals International,
- Indevus Pharmaceuticals,
Request COVID Analysis on Cannabinoid Drugs Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=78851
Global Cannabinoid Drugs Market: Key Trends and Drivers
A large number of people across the world are suffering from chronic conditions. Survivors of cancer often suffer from debilitating pain due to the disease itself or the therapy given. An increased requirement of pain management therapy due to growing number of cases of post cancer chronic pain is anticipated to drive the cannabinoid drugs market in the near future.
- Psychotherapy is demanding cannabinoid intervention on an increased scale given the benefits it has for patients with hyperactive disorders. Since psychiatric diagnosis has become reasonably accurate with time, this will upscale demand for cannabinoid drugs.
- Due to strict regulations for THC, adoption of the full spectrum of cannabinoid isolates in a number of countries is low. Physicians are also prescribing the parts of medical marijuana owing to its entourage effect. But rising pressure from the medical community on legal bodies to legalize cannabis products is anticipated to positively influence the demand for full-spectrum extracts in the future.
Pre Book Cannabinoid Drugs Market Report –
https://www.transparencymarketresearch.com/checkout.php?rep_id=78851<ype=S
Global Cannabinoid Drugs Market: Regional Analysis
Since 2012 cannabis usage has been legalized in the United States, with eleven states including the Columbia having taken steps in this direction. Moreover, a growing geriatric population in this region is expected to raise the prevalence of chronic conditions. The number of people aged 60 years and above will double till 2060 in the United States, according to the World Health Organization. Hence, North America is anticipated to be dominant in the global cannabinoid drugs market.
In 2019, Europe accounted for the second largest revenue share of the cannabinoid drugs market. Italy is regarded as the fourth largest consumer of concentrates of cannabis. However, stringent rules and regulations surrounding the sale and cultivation of cannabis plants may limit the overall growth of the cannabinoid drugs market in Europe.
Request Customization on Cannabinoid Drugs Market Report –
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=78851
The Asia Pacific region (APAC) is yet to recognize cannabis as a potential drug therapy regime and hence the cannabinoid drugs market has little foothold here. The same holds true for areas of Africa and the Middle East. Thus, the cannabinoid drugs market finds acceptance only in the developed regions currently, though increased westernization of the developing world might fuel growth in these regions.
Trending Reports of Transparency Market Research –
Laparoscopy Devices Market –
Tuberculosis Testing Market –
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com
